There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To evaluate Ozurdex (dexamethasone intravitreal implant [DEX implant]; Allergan, Inc,
Irvine, CA) 0.7 mg combined with laser photocoagulation compared with laser alone
for treatment of diffuse diabetic macular edema (DME).